PubMed

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition.

Laterre PF.

Crit Care. 2008;12 Suppl 6:S4. Epub 2008 Nov 26. Review.PMID: 19105797 [PubMed - indexed for MEDLINE]Related articlesFree article

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.

Laterre PF, Opal SM, Abraham E, LaRosa SP, Creasey AA, Xie F, Poole L, Wunderink RG.

Crit Care. 2009;13(2):R36. Epub 2009 Mar 15.PMID: 19284881 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy.

Mira JP, Max A, Burgel PR.

Crit Care. 2008;12 Suppl 6:S5. Epub 2008 Nov 26. Review.PMID: 19105798 [PubMed - indexed for MEDLINE]Related articlesFree article

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.

Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, Bates B, Yan SC, Dhainaut JF; PROWESS Clinical Evaluation Committee.

Crit Care Med. 2005 May;33(5):952-61.PMID: 15891319 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group.

JAMA. 2003 Jul 9;290(2):238-47.PMID: 12851279 [PubMed - indexed for MEDLINE]Related articlesFree article

Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.

Ioachimescu OC, Ioachimescu AG, Iannini PB.

Int J Antimicrob Agents. 2004 Nov;24(5):485-90.PMID: 15519482 [PubMed - indexed for MEDLINE]Related articles

Adjunctive therapy in community-acquired pneumonia.

Wunderink RG.

Semin Respir Crit Care Med. 2009 Apr;30(2):146-53. Epub 2009 Mar 18. Review.PMID: 19296414 [PubMed - indexed for MEDLINE]Related articles

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

Rello J, Rodriguez A, Lisboa T, Gallego M, Lujan M, Wunderink R.

Crit Care Med. 2009 Feb;37(2):456-62.PMID: 19114916 [PubMed - indexed for MEDLINE]Related articles

Prospective evaluation of the treatment and outcome of community-acquired pneumonia according to the Pneumonia Severity Index in VHA hospitals.

Davydov L, Ebert SC, Restino M, Gardner M, Bedenkop G, Uchida KM, Bertino JS Jr.

Diagn Microbiol Infect Dis. 2006 Apr;54(4):267-75. Epub 2006 Feb 8.PMID: 16466891 [PubMed - indexed for MEDLINE]Related articles

Current guidelines for the treatment of severe pneumonia and sepsis.

Bodmann KF.

Chemotherapy. 2005 Aug;51(5):227-33. Review.PMID: 16103664 [PubMed - indexed for MEDLINE]Related articles

Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

Marrie TJ, Shariatzadeh MR.

Medicine (Baltimore). 2007 Mar;86(2):103-11.PMID: 17435590 [PubMed - indexed for MEDLINE]Related articles

Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia.

Georges H, Leroy O, Vandenbussche C, Guery B, Alfandari S, Tronchon L, Beaucaire G.

Intensive Care Med. 1999 Feb;25(2):198-206.PMID: 10193548 [PubMed - indexed for MEDLINE]Related articles

Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.

Bodí M, Rodríguez A, Solé-Violán J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators.

Clin Infect Dis. 2005 Dec 15;41(12):1709-16. Epub 2005 Nov 9.PMID: 16288392 [PubMed - indexed for MEDLINE]Related articles

Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia.

Bruns AH, Oosterheert JJ, Hustinx WN, Gaillard CA, Hak E, Hoepelman AI.

Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):913-9. Epub 2009 Mar 12.PMID: 19280235 [PubMed - indexed for MEDLINE]Related articlesFree article

Improving outcomes of elderly patients with community-acquired pneumonia.

Gutiérrez F, Masiá M.

Drugs Aging. 2008;25(7):585-610. Review.PMID: 18582147 [PubMed - indexed for MEDLINE]Related articles

Severe community-acquired pneumonia.

Restrepo MI, Anzueto A.

Infect Dis Clin North Am. 2009 Sep;23(3):503-20. Review.PMID: 19665080 [PubMed - indexed for MEDLINE]Related articles

Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.

Yu KT, Wyer PC.

Ann Emerg Med. 2008 May;51(5):651-62, 662.e1-2. Epub 2008 Feb 13. Review.PMID: 18272253 [PubMed - indexed for MEDLINE]Related articles

Assessment of severity of community-acquired pneumonia.

Boersma WG.

Semin Respir Infect. 1999 Jun;14(2):103-14. Review.PMID: 10391405 [PubMed - indexed for MEDLINE]Related articles

Novel targets in the management of pneumonia.

Díaz LA, Mortensen EM, Anzueto A, Restrepo MI.

Ther Adv Respir Dis. 2008 Dec;2(6):387-400. Review.PMID: 19124384 [PubMed - indexed for MEDLINE]Related articles

Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study.

Marik P, Kraus P, Sribante J, Havlik I, Lipman J, Johnson DW.

Chest. 1993 Aug;104(2):389-92.PMID: 8339624 [PubMed - indexed for MEDLINE]Related articlesFree article